Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases

Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases

Since 1946 the development of fractionation and purification methods of human plasma led to biologic immunoglobulin for intravenous use (IVIG). In 1980 a child with refractory immune thrombocytopenia (ITP), bleeding and secondary hypogammaglobulinaemia due to long term immunosuppressive treatm...

Full description

Bibliographic Details
Main Author:	Paul Imbach
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2012-05-01
Series:	Swiss Medical Weekly
Subjects:	historical review immune thrombocytopenia intravenous immuneglobuline
Online Access:	https://www.smw.ch/index.php/smw/article/view/1488

Similar Items

A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report
by: Tarinee Rungjirajittranon, et al.
Published: (2019-01-01)

Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia
by: Chul Hee Kim, et al.
Published: (2019-03-01)

Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis
by: Xiangge Ren, et al.
Published: (2024-03-01)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
by: Thomas Rogier, et al.
Published: (2020-06-01)

Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin‐induced thrombocytopenia: A propensity matched analysis
by: Alexandre Soares Ferreira Júnior, et al.
Published: (2021-08-01)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
by: Philipp Scheuerlein, et al.
Published: (2018-07-01)

Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia
by: Rick Kapur, et al.
Published: (2017-07-01)

Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
by: Yun Liu, et al.
Published: (2023-03-01)

Intravenous Immunoglobulin Responsive Persistent Thrombocytopenia after Dengue Haemorrhagic Fever
by: Prabhat Kumar, et al.
Published: (2016-04-01)

Corrigendum: Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
by: Yun Liu, et al.
Published: (2024-04-01)

Evolving treatment modalities for immune thrombocytopenia in adults
by: Sushmita Khadka, et al.
Published: (2021-01-01)

Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
by: María Eva Mingot-Castellano, et al.
Published: (2023-10-01)

Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
by: Fehmi Hindilerden, et al.
Published: (2020-07-01)

An infant with refractory cytomegalovirus‐induced thrombocytopenia
by: Suguru Uemura, et al.
Published: (2020-01-01)

Case report: Follow-up, diagnosis, clinical evidence, laboratory evaluation, and treatment of Idiopathic thrombocytopenia using human Intravenous Immunglobulin in a terrier dog
by: Ezzatollah Fathi, et al.
Published: (2014-06-01)

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
by: Crickx E, et al.
Published: (2023-01-01)

Diagnosis and management of coronavirus disease-associated immune thrombocytopenia: a case series
by: Fatma Yılmaz Aydın, et al.
Published: (2021-04-01)

Severe immune thrombocytopenia in a critically ill COVID-19 patient
by: Ziga Martincic, et al.
Published: (2020-10-01)

Clinical efficacy of immunoglobulin on the treatment of severe fever with thrombocytopenia syndrome: a retrospective cohort studyResearch in context
by: Shan-Shan Zhang, et al.
Published: (2023-10-01)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
by: Bonnie J.B. Lewis, et al.
Published: (2021-11-01)

Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban
by: Farheen Manji, et al.
Published: (2020-01-01)

Immunosuppressive treatment for immune thrombocytopenia which masked Graves′ disease
by: Suleyman Baldane, et al.
Published: (2015-01-01)

Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
by: Deirdra R. Terrell, et al.
Published: (2020-11-01)

Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
by: Anurag Singh, et al.
Published: (2021-02-01)

Safety of Immunization for Children with Immune Thrombocytopenia
by: Xiangshi Wang, et al.
Published: (2024-01-01)

A Case of Vancomycin-Induced Severe Immune Thrombocytopenia
by: Shivani Shah, et al.
Published: (2023-04-01)

Total remission of severe immune thrombocytopenia after short term treatment with romiplostim
by: Efthymia Vlachaki, et al.
Published: (2011-10-01)

How I approach new onset thrombocytopenia
by: Fiona Swain, et al.
Published: (2020-04-01)

Editorial: Immune thrombocytopenia (ITP)—diagnosis and treatment
by: Tomás José González-López
Published: (2024-03-01)

An antivenin resistant, IVIg-corticosteroids responsive viper induced thrombocytopenia
by: Matteo Turetta, et al.
Published: (2022-01-01)

A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
by: Gurleen Oberoi, et al.
Published: (2022-01-01)

Recent advances in the mechanisms and treatment of immune thrombocytopenia
by: Drew Provan, et al.
Published: (2022-02-01)

A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome
by: Alaa Rahhal, et al.
Published: (2024-04-01)

Immune thrombocytopenia associated with tuberculosis – A case report
by: Adeel Ahmad Khan, et al.
Published: (2021-01-01)

Autoimmune Heparin-Induced Thrombocytopenia after Transcatheter Aortic Valve Implantation: Successful Treatment with Adjunct High-Dose Intravenous Immunoglobulin
by: Tamam Bakchoul, et al.
Published: (2019-04-01)

Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report
by: İsmail Beypinar, et al.
Published: (2017-04-01)

Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in Children
by: Angela Guarina, et al.
Published: (2021-04-01)

Primary immune thrombocytopenia in children
by: Agnieszka Książek, et al.
Published: (2021-03-01)

Tuberculosis presenting as immune thrombocytopenia
by: Deepak Moka, et al.
Published: (2022-01-01)

Fibrinogen levels are associated with bleeding in patients with primary immune thrombocytopenia
by: Min Xu, et al.
Published: (2020-08-01)